High-dose chemotherapy and autologous bone marrow transplant in relapsed Hodgkin's disease--a pragmatic prognostic index.

High-dose chemotherapy with autologous bone marrow transplantation is used in the treatment of relapsed or high-risk Hodgkin's disease. As prospective randomised studies have proved difficult to accrue to, current recommendations are based on the reports of large series of prospectively collect...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Brien, M. E., Milan, S., Cunningham, D., Jones, A. L., Nicolson, M., Selby, P., Hickish, T., Hill, M., Gore, M. E., Viner, C.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074518/
https://www.ncbi.nlm.nih.gov/pubmed/8630292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074518/
https://www.ncbi.nlm.nih.gov/pubmed/8630292

Ejemplares similares